New-onset diabetes after kidney transplantation: Risk factors

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 3, 2006, Pages

  Rodrigo, Emilio ^a   Fernández Fresnedo, Gema ^a   Valero, Rosalía ^a   Ruiz, Juan Carlos ^a   Piñera, Celestino ^a   Palomar, Rosa ^a   González Cotorruelo, Julio ^a   Gómez Alamillo, Carlos ^a   Arias, Manuel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS;

AGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; GENETICS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMPAIRED GLUCOSE TOLERANCE; NEW ONSET DIABETES AFTER KIDNEY TRANSPLANTATION; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE; RECIPIENT; RISK FACTOR; SIDE EFFECT; SURVIVAL;

EID: 33845257355     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080929     Document Type: Conference Paper

References (37)

1. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der woude FJ, Wheeler DC: New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75[Suppl 10]: S3-S24, 2003
2. Miles AM, Sumrani N, Horowitz R, Homel P, Maursky V, Markell MS, Distant DA, Hong JH, Sommer BG, Friedman EA: Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 65: 380-384, 1998
3. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003
4. Fernandez-Fresnedo G, Escallada R, de Francisco ALM, Rodrigo E, Zubimendi JA, Ruiz JC, Pinera C, Herraez I, Arias M: Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc 35: 700, 2003
5. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T: The impact of early-diagnosed new-onset post-transplant diabetes mellitus on survival and major cardiac events. Kidney Int 69: 588-595, 2006
6. Ducloux D, Kazory A, Chalopin J-M: Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 79: 438-443, 2005
7. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD: New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67: 2415-2421, 2005
8. Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, Matsuura S, Saito M, Tada H, Suzuki T, Habuchi T: Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 80: 1419-1424, 2005
9. Sumrani NB, Delaney V, Ding Z, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH: Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors. Transplantation 51: 343-347, 1991
10. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM: Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59: 732-737, 2001
11. Montori VM, Velosa JA, Basu A, Gabriel SE, Erwin PJ, Kudva YC: Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 25: 583-592, 2002
12. Risaeter AV, Hartmann A: Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc 33[Suppl 5A]: S8-S18, 2001
13. Rodrigo E, Pinera C, de Cos MA, Sanchez B, Ruiz JC, Fernandez-Fresnedo G, Palomar R, Gonzalez-Cotorruelo J, Gomez-Alamillo C, Sanz de Castro S, Martin de Francisco AL, Arias M: Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transpl Int 18: 1152-1157, 2005
14. Rames Prasad GV, Kim SJ, Huang M, Nash MM, Zaltzman JS, Fenton SSA, Cattran DC, Cole EH, Cardella CJ: Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins). Am J Transplant 4: 1897-1903, 2004
15. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM: Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am J Transplant 4: 1876-1882, 2004
16. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients. Am J Transplant 3: 590-598, 2003
17. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB: New-onset diabetes after kidney transplantation: An application of 2003 international guidelines. Transplantation 80: 945-952, 2005
18. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrom J, Leivestad T, Egeland T, Fauchald P: Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64: 979-983, 1997
19. Maes BD, Kuypers D, Messiaen T, Evenepoel P, Mathieu C, Coosemans W, Pirenne J, Vanrenterghem YF: Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation 72: 1655-1661, 2001
20. Romagnoli J, Citterio F, Violi P, Cadeddu F, Nanni G, Castagneto M: Post-transplant diabetes mellitus: A case-control analysis of the risk factors. Transpl Int 18: 309-312, 2005
21. Tuomilehto J, Linstrom J, Eriksson JG, Valle TI, Hamalainen H, Ilanne-Parikka P; for the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350, 2001
22. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T: Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 47: 1550-1556, 2004
23. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G: Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies. Am J Transplant 5: 2433-2440, 2005
24. Heisel O, Heisel R, Balshaw R, Keown P: New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 4: 583-595, 2004
25. Boots JMM, van Duijnhoven EM, Christiaans MHL, Wolffenbuttel BHR, van Hoof JP: Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 13: 221-227, 2002
26. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T: Insulin resistance after renal transplantation: The effect of steroid reduction and withdrawal. J Am Soc Nephrol 15: 3233-3239, 2004
27. Vanrenterghem Y, van Hooff JP, Squifflet JP, Salmela K, Rigotti P, Jindal RM, Pascual J, Ekberg H, Sicilia LS, Boletis JN, Grinyo JM, Rodriguez MA; European Tacrolimus/MMF Renal Transplantation Study Group: Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant 5: 87-95, 2005
28. Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P; the CARMEN Study Group: Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 79: 807-814, 2005
29. Woodle ES; for the Fujisawa Corticosteroid Withdrawal Study Group: A prospective, randomized, multicenter, double-blind study of early corticosteroids cessation versus long-term maintenance of corticosteroids therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: One year report. Transplant Proc 37: 804-808, 2005
30. Webster AC, Woodrofe RC, Taylor RS, Chapman JR, Craig JC: Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomized trial data. BMJ 331: 810-821, 2005
31. Van Duijnhoven EM, Boots JM, Christiaans MHL, Wolffenbuttel BHR, van Hoof JP: Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study. J Am Soc Nephrol 12: 583-588, 2001
32. Gelens M, Christiaans M, Undre N, Karpf C, Dackus J, Hoof JV: Tacrolimus and glucose metabolism: Peak level or oral bioavailability [Abstract]. Am J Transplant 5[Suppl 11]: 653, 2005
33. Van Hooff JP, Christiaans MHL, van Duijnhoven EM: Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 79: 1465-1469, 2005
34. Teutonico A, Schena PF, Di Paolo S: Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16: 3128-3135, 2005
35. Egidi MF, Cowan PA, Naseer A, Gaber AO: Conversion to sirolimus in solid organ transplantation: A single-center experience. Transplant Proc 35[Suppl 3]: S131-S137, 2003
36. Hricik DE, Anton HA, Knauss TC, Rodriguez V, Seaman D, Siegel C, Valente J, Schulak JA: Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 74: 189-193, 2002
37. Rodrigo E, Ruiz JC, Castañeda O, Valero R, Piñera C, Fresnedo GF, Palomar R, Cotorruelo JG, Alamillo CG, Arias M: Switching from calcineurin inhibitors to sirolimus impairs glucose metabolism [Abstract]. Am J Transplant 6[Suppl 2]: 941, 2006